188 related articles for article (PubMed ID: 22133428)
1. Evoked dopamine overflow is augmented in the striatum of calcitriol treated rats.
Cass WA; Peters LE; Fletcher AM; Yurek DM
Neurochem Int; 2012 Jan; 60(2):186-91. PubMed ID: 22133428
[TBL] [Abstract][Full Text] [Related]
2. Calcitriol promotes augmented dopamine release in the lesioned striatum of 6-hydroxydopamine treated rats.
Cass WA; Peters LE; Fletcher AM; Yurek DM
Neurochem Res; 2014 Aug; 39(8):1467-76. PubMed ID: 24858239
[TBL] [Abstract][Full Text] [Related]
3. Reduced ability of calcitriol to promote augmented dopamine release in the lesioned striatum of aged rats.
Cass WA; Peters LE
Neurochem Int; 2017 Sep; 108():222-229. PubMed ID: 28390950
[TBL] [Abstract][Full Text] [Related]
4. Neurturin effects on nigrostriatal dopamine release and content: comparison with GDNF.
Cass WA; Peters LE
Neurochem Res; 2010 May; 35(5):727-34. PubMed ID: 20119638
[TBL] [Abstract][Full Text] [Related]
5. Functional effects of GDNF in normal rat striatum: presynaptic studies using in vivo electrochemistry and microdialysis.
Hebert MA; Van Horne CG; Hoffer BJ; Gerhardt GA
J Pharmacol Exp Ther; 1996 Dec; 279(3):1181-90. PubMed ID: 8968339
[TBL] [Abstract][Full Text] [Related]
6. Augmented methamphetamine-induced overflow of striatal dopamine 1 day after GDNF administration.
Cass WA; Walker DJ; Manning MW
Brain Res; 1999 May; 827(1-2):104-12. PubMed ID: 10320698
[TBL] [Abstract][Full Text] [Related]
7. Restorative effects of GDNF on striatal dopamine release in rats treated with neurotoxic doses of methamphetamine.
Cass WA; Manning MW; Bailey SL
Ann N Y Acad Sci; 2000 Sep; 914():127-36. PubMed ID: 11085315
[TBL] [Abstract][Full Text] [Related]
8. Neurturin protects against 6-hydroxydopamine-induced reductions in evoked dopamine overflow in rat striatum.
Cass WA; Peters LE
Neurochem Int; 2010 Nov; 57(5):540-6. PubMed ID: 20615442
[TBL] [Abstract][Full Text] [Related]
9. Intranigral ventral mesencephalic grafts and nigrostriatal injections of glial cell line-derived neurotrophic factor restore dopamine release in the striatum of 6-hydroxydopamine-lesioned rats.
Tang FI; Tien LT; Zhou FC; Hoffer BJ; Wang Y
Exp Brain Res; 1998 Apr; 119(3):287-96. PubMed ID: 9551829
[TBL] [Abstract][Full Text] [Related]
10. Recovery of presynaptic dopaminergic functioning in rats treated with neurotoxic doses of methamphetamine.
Cass WA; Manning MW
J Neurosci; 1999 Sep; 19(17):7653-60. PubMed ID: 10460271
[TBL] [Abstract][Full Text] [Related]
11. GDNF protection against 6-OHDA-induced reductions in potassium-evoked overflow of striatal dopamine.
Cass WA; Manning MW
J Neurosci; 1999 Feb; 19(4):1416-23. PubMed ID: 9952418
[TBL] [Abstract][Full Text] [Related]
12. Effect of AdGDNF on dopaminergic neurotransmission in the striatum of 6-OHDA-treated rats.
Smith AD; Kozlowski DA; Bohn MC; Zigmond MJ
Exp Neurol; 2005 Jun; 193(2):420-6. PubMed ID: 15869944
[TBL] [Abstract][Full Text] [Related]
13. Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects dopaminergic terminals from degeneration.
Connor B; Kozlowski DA; Unnerstall JR; Elsworth JD; Tillerson JL; Schallert T; Bohn MC
Exp Neurol; 2001 May; 169(1):83-95. PubMed ID: 11312561
[TBL] [Abstract][Full Text] [Related]
14. Calcitriol protection against dopamine loss induced by intracerebroventricular administration of 6-hydroxydopamine.
Smith MP; Fletcher-Turner A; Yurek DM; Cass WA
Neurochem Res; 2006 Apr; 31(4):533-9. PubMed ID: 16758362
[TBL] [Abstract][Full Text] [Related]
15. Bilateral effects of unilateral GDNF administration on dopamine- and GABA-regulating proteins in the rat nigrostriatal system.
Salvatore MF; Gerhardt GA; Dayton RD; Klein RL; Stanford JA
Exp Neurol; 2009 Sep; 219(1):197-207. PubMed ID: 19460370
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 protein Tat potentiation of methamphetamine-induced decreases in evoked overflow of dopamine in the striatum of the rat.
Cass WA; Harned ME; Peters LE; Nath A; Maragos WF
Brain Res; 2003 Sep; 984(1-2):133-42. PubMed ID: 12932847
[TBL] [Abstract][Full Text] [Related]
17. Calcitriol protects against the dopamine- and serotonin-depleting effects of neurotoxic doses of methamphetamine.
Cass WA; Smith MP; Peters LE
Ann N Y Acad Sci; 2006 Aug; 1074():261-71. PubMed ID: 17105922
[TBL] [Abstract][Full Text] [Related]
18. Microdialysis studies of basal levels and stimulus-evoked overflow of dopamine and metabolites in the striatum of young and aged Fischer 344 rats.
Gerhardt GA; Maloney RE
Brain Res; 1999 Jan; 816(1):68-77. PubMed ID: 9878690
[TBL] [Abstract][Full Text] [Related]
19. Calcitriol protects against reductions in striatal serotonin in rats treated with neurotoxic doses of methamphetamine.
Cass WA; Peters LE
Neurochem Int; 2023 Oct; 169():105590. PubMed ID: 37536650
[TBL] [Abstract][Full Text] [Related]
20. CGP 56999A, a GABA(B) receptor antagonist, enhances expression of brain-derived neurotrophic factor and attenuates dopamine depletion in the rat corpus striatum following a 6-hydroxydopamine lesion of the nigrostriatal pathway.
Enna SJ; Reisman SA; Stanford JA
Neurosci Lett; 2006 Oct; 406(1-2):102-6. PubMed ID: 16890350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]